Medical Information Only. Always consult your healthcare provider before enrolling in any clinical trial.
NCT05836818 · ClinicalTrials.gov registry record · NA
PROmotion of FLU Vaccine Uptake in the Emergency Department - PROFLUVAXED
A NA study, sponsored by University of California, San Francisco.
- Completed
- Registry status
- NA
- Development phase
- 776
- Enrollment target
NCT05836818 is a NA study that has completed, run by University of California, San Francisco. The registered enrollment target is 776 participants.
The verdict
NCT05836818, a NA study, has completed, sponsored by University of California, San Francisco.
- COMPLETED
- Registry status
- NA
- Development phase
- 776 participants
- Enrollment target
Study Summary
The goal of this research is to increase influenza vaccine acceptance and uptake in vulnerable populations whose primary (and often only) health care access occurs in emergency departments (ED Usual Source of Care Patients). Toward this goal, the investigators will conduct one on one interviews and focus groups with ED Usual Source of Care Patients and community partners and produce trusted messaging informational platforms (PROmotion of FLU VA(X)ccination in the Emergency Department - PROFLUVAXED) that will address barriers to flu vaccination, especially vaccine hesitancy. The investigators will then conduct a cluster-randomized, controlled trial of PROFLUVAXED platforms in six EDs to determine whether their implementation is associated with greater flu vaccine acceptance and uptake in ED Usual Source of Care Patients.
Interventions
- OTHER Question (Q)
- OTHER Messaging (M)
Trial Details
| Field | Value |
|---|---|
| Enrollment Target | 776 participants |
| Start Date | 2022-10-01 |
| Est. Completion | 2023-03-30 |
| Phase | NA |
Interested in This Trial?
Full Details on ClinicalTrials.gov ↗What the Registry Record Tells You About NCT05836818
The ClinicalTrials.gov registry entry for NCT05836818 describes a study currently listed as completed, categorized as NA. The registered enrollment target is 776 participants, a figure that helps gauge the scale of data the investigators plan to collect. The listed sponsor is University of California, San Francisco, which has 1,713 total studies on file at ClinicalTrials.gov.
The record links to 0 conditions, and to 2 interventions - of which Question (Q) is the first listed.
NCT05836818 reports 0 study locations.
Frequently Asked Questions
What is clinical trial NCT05836818 about?
NCT05836818 is a clinical study titled "PROmotion of FLU Vaccine Uptake in the Emergency Department - PROFLUVAXED". The goal of this research is to increase influenza vaccine acceptance and uptake in vulnerable populations whose primary (and often only) health care access occurs in emergency departments (ED Usual Source of Care Patients). Toward this goal, the investigators will conduct one on one interviews and ...
What is the current status of trial NCT05836818?
This trial is currently completed. It is a NA study. The enrollment target is 776 participants. The study started on 2022-10-01. Estimated completion is 2023-03-30.
What interventions are being tested in trial NCT05836818?
The interventions under investigation include: Question (Q) (OTHER), Messaging (M) (OTHER).
Who is sponsoring clinical trial NCT05836818?
This trial is sponsored by University of California, San Francisco, which has 1,713 total clinical trials registered on ClinicalTrials.gov.
Learn More About Clinical Trials
Explore more on PlainTrial
Read our methodology - how this data is sourced, computed, and verified.
Related
Every figure on PlainTrial is rendered directly from the ClinicalTrials.gov registry, no number is typed in by an editor. This page mirrors this trial's own ClinicalTrials.gov registry record, live from the dataset. See our editorial standards & corrections policy, the methodology behind these numbers, or report a data error.